ArticleInfectious diseases and therapy2025

Preventing Severe COVID-19 with Tixagevimab-Cilgavimab in Hematological Patients Treated with Anti-CD20 Monoclonal Antibodies: An International Multicenter Study.

Hovav Azuly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.